November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Lou Lanza: Another successful evening at the AstraZeneca Hope Lodge
Nov 11, 2024, 17:06

Lou Lanza: Another successful evening at the AstraZeneca Hope Lodge

Lou Lanza, Retired Mechanical Engineer last working for BB&E Consulting Engineers and Professionals, shared a post on LinkedIn:

“Another successful evening at the AstraZeneca Hope Lodge. A little wrinkle this time. Thanks to Kim Mosley of the Cathy Miller Cancer Fund team for inviting me and the Flyers for arranging this feast for the Patients and their Caregivers staying at the Lodge.

I brought my obligatory pizzelles, cream puffs and eclairs. I broke bread with Michelle and Jeff from Delaware. I was surprised and pleased to see Paula Green of the ACS. Also got to meet the newest Philly Sports Mascot sensation.”

“Lou Lanza you inspire me every day. I know that you brightened the day of those in the Lodge – as you always do – and I am thankful.

You and Gritty DePhila make a powerful team!”

Lou Lanza: Another successful evening at the AstraZeneca Hope Lodge

More posts featuring Karen Knudsen.

Lou Lanza is a retired Mechanical Engineer who most recently worked at BB&E Consulting Engineers and Professionals, following a career of over 40 years with AECOM and its predecessor companies. He is currently volunteering with the Jefferson Hospital Sidney Kimmel Cancer Center’s Buddy Program, offering support to newly diagnosed cancer patients by helping them understand what to expect and how to manage the challenges ahead.

Karen E. Knudsen is the past CEO of the American Cancer Society (ACS). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR).

She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.